Digital Marketing Has Entered a Red Ocean: How Can Innovative Pharma Companies Break Through?

Pharmaceutical companies' digital marketing has now officially entered"Red Ocean" Phase.

Currently, an increasing number of innovative pharmaceutical companies are entering the window period for drug market launch, while traditional pharmaceutical enterprises are also undergoing transformation. By providing support to various stakeholders, including pharmaceutical companies, physicians, and patients, digital marketing has become one of the key pathways for pharmaceutical companies to pursue digital transformation.

Against this backdrop, the core pain point for pharmaceutical companies has shifted from how to launch digital marketing initiatives from scratch to how to stand out in the “red ocean” of digital marketing.

How can pharmaceutical companies, especially innovative drug developers, identify the digital marketing breakthrough strategy best suited to their needs?

To answer this question,August 31, 2022, 20:00–21:30，Artery SelectJoin HandsKanin TechnologyCo-hosted by“The Red Ocean of Digital Marketing Has Arrived: How Can Innovative Pharmaceutical Companies ‘Break Through the Siege’?”Live Online Open Course. During the session, Gong Huijuan, CEO of Kaning Technology, will draw on her years of experience in managing physician-patient relationships and accumulated practical case studies to explore feasible digital marketing solutions for innovative pharmaceutical companies.

Not only that, this session also invitedHead of Oncology Patient Education and Communications, HengruiWang Qin、Qiu Ning, President of Alog ChinaandYang Weijun, Head of Growth Strategy Consulting at TaochangParticipate Together[The Significance and Value of Building a New Doctor-Patient Relationship for the Digital Transformation of Innovative Pharmaceutical Companies]Roundtable Discussion: Helping Innovative Pharmaceutical Companies Accelerate Their Path to Advanced Digital Marketing.

For readers participating in this open lecture, we will additionally provideOpen Course Preview Materials, Course Content Summaries, and Premium Healthcare Industry ResourcesScan the QR code on the poster below to join the group and reserve your spot for the live stream, and you’ll receive valuable resources such as reports.

During the live broadcast, there will also be30 Packages of Doctor Digital Studio Services, with a Total Value of RMB 600,000Available for claim! Limited quantities, first come, first served!

1. Cognition: The Inevitable Trend of Digital Marketing and Its Five Major Pitfalls.

2. Key: Doctor-centric, patient-centered.

3. Pathway: Connecting pharmaceutical companies, physicians, and patients by embracing a digital lean model.

4. Sharing: Breakdown of Practical Cases.

Founders and Partners of Innovative and High-Growth Pharmaceutical Companies

[Recommendation: ★★★★★]

Vice President-Level Management at Innovative and High-Growth Pharmaceutical Companies

[Recommendation: ★★★★]

Marketing Director at Innovative and High-Growth Pharmaceutical Companies

[Recommendation: ★★★]

If you belong to the above-mentioned groups, please do not miss this information-packed open lecture.

A leading expert in the practical management of new doctor-patient relationships, with many years of experience in the pharmaceutical industry. He has built doctor-patient service systems for numerous domestic and foreign pharmaceutical companies and physicians, establishing a clear closed-loop pathway among “pharmaceutical companies–physicians–patients.” In some cases, client pharmaceutical companies achieved sales growth from under RMB 500 million to RMB 1.4 billion within three years.

Currently responsible for public communications, patient management, innovative payment solutions, and commercial insurance services for oncology innovation products. Committed to building a digital-based patient service ecosystem that aligns with brand strategy and addresses the needs of cancer patients, thereby enhancing their diagnostic and treatment experience and quality of life. Previously spent over 10 years at leading multinational corporations, holding roles in Marketing and Medical Affairs departments, with a focus on patient loyalty brand management, media relations, and innovation. Led the largest patient loyalty brand project in a specific therapeutic area for nearly a decade, establishing it as an industry benchmark and earning the company’s Global Innovation Award.

Previously held senior management positions at multiple global pharmaceutical companies in China. Currently actively promoting the standardization of diagnosis and allergen immunotherapy for allergic diseases in China, pioneering a patient-centered whole-disease-course management model, and committed to introducing more high-quality allergy-related products to the Chinese market. Dedicated to providing advanced, high-quality products and technologies to clinical professionals in China, helping patients with allergic conditions avoid the burdens of allergies and regain their quality of life.

Ph.D. in Management from a Belgian Business School, with a background in Clinical Medicine; possesses over 20 years of experience in marketing strategy and management consulting within the pharmaceutical industry. As an expert in strategic research and consulting for the digital transformation of the pharmaceutical sector through internet technologies and big data, has formulated marketing strategies for more than 50 large- and medium-sized listed companies and high-growth pharmaceutical enterprises, focusing on the research and implementation of omnichannel, multi-model growth strategies in the context of the current era.

Kaning Technology was founded in 2017 and is committed to providing customized “Internet + Patient Services” system solutions for pharmaceutical companies, helping them upgrade and transform from “products” to “services.” Its existing products and services cover major disease areas including cardiovascular diseases, nephrology, dermatology, pediatrics, and ophthalmology.

Hengrui Medicine, founded in 1970, is an international pharmaceutical company dedicated to the research, development, and promotion of innovative and high-quality medicines. It has grown into a well-known domestic supplier of anti-tumor drugs, perioperative medications, and imaging and interventional products. For over five decades, Hengrui Medicine has remained rooted in China while embracing a global perspective, committing itself to the healthcare sector, focusing on cutting-edge fields, and overcoming challenges to drive the high-quality development of the pharmaceutical industry.

ALK-Abelló holds a leading position globally in the diagnosis and desensitization therapy of allergic diseases. With over 50 years of history, this German company offers a comprehensive product portfolio covering allergen diagnostics, desensitization preparations, allergen protection products, and emergency treatments for anaphylactic shock. It is the sole provider of "dual-mite desensitization preparations" in China.

Taochang Growth Strategy Consulting is an innovative service agency, recently founded by industry veterans, dedicated to providing in-depth services to early-stage enterprises in the pharmaceutical and healthcare industries. Leveraging capabilities in “intellectual capital (strategic roadmap) + growth operational resources + financial capital (corporate financing),” we focus on specific diseases and therapeutic areas. Centered on the patient-physician lifecycle and driven by data as a foundational and long-term engine, we prioritize medical devices and Western medicines as the core, with traditional Chinese medicine as a complementary strength. We link innovation and connect innovators to drive corporate performance growth and the continuous enhancement of core competitiveness. Co-founders Mr. Huang Cheng, Chairman of Rongtai Communication and Zhengye Technology, and Mr. Zhou Manyi, Chairman of Fengxiang Chuan Shuo, possess over 20 years of experience in brand strategy formulation and integrated marketing within the pharmaceutical and healthcare sectors. They have previously served more than 100 mainstream pharmaceutical companies in China. Currently, Taochang has assembled a team of nearly 100 consultants and technical experts in Shanghai and Beijing.

“Artery Open Class” is one of the branded columns under VCBeat’s “VCBeat Select.” Centered on addressing development pain points and exploring systematic solutions within the healthcare sector, it leverages an online live-streaming platform for knowledge sharing and exchange. By continuously inviting seasoned industry practitioners and experts to collaboratively develop and deliver a series of thematic courses, it aims to provide healthcare enterprises with in-depth, high-value, practical content. Artery Open Class: Making the selection of knowledge simpler.